Edward Graham is Senior Analyst/Consultant, previously responsible for all healthcare positions in the UBS U.S. Small Cap Funds. He has 13 years of buy-side experience in Healthcare with a specialty in Medical Devices and Biotech investing. While at UBS, he developed a unique biotech investment strategy that captured alpha and reduced event risk. The strategy involved buying a basket of small cap biotech stocks with strong cash positions, diverse pipelines, and solid management teams. Edward is dedicated to growth investing with expertise as a partner for an independent asset management boutique and as an investment team member for a multinational financial institution. Unique accomplishments include driving the growth of a start-up investment firm from $250M to $2B in AUM.